Equity Research Energy and Power Technologies | Rare Earth August 12, 2026 Neal Dingmann +1 312 801 7835 [email protected] Second-Quarter Miss and 2026 Guidance Decreased, Though Government Shipments Increasing Stock Rating: United States…
Equity Research
Energy and Power Technologies | Rare Earth
August 12, 2026
Neal Dingmann +1 312 801 7835
[email protected]
Second-Quarter Miss and 2026 Guidance Decreased, Though Government
Shipments Increasing
Stock Rating:
United States Antimony Corporation
Production to Ramp Up. US Antimony expanded its antimony base feedstock during the
second quarter, with overall inventory rising 178% year-to-date as the company secured
material from various sources, including third-party suppliers, Stibnite Hill in Montana, Mexico,
and newly established Bolivian supply channels. Roughly 300 tons of metallic feedstock
have recently been received or are inbound for processing, while Bolivia is expected to ramp
up toward approximately 160 tons per month. This diversified sourcing strategy reduces
feedstock risk and strengthens supply security as the company increases production. We
believe the solid feedback ensuring continued production signals positive near-term growth
potential as the company proactively builds up its inventory and supply flexibility, all while
ahead of the rising demand curve from government and commercial customers.
Thompson Falls & Radersburg Expansion Reaching Commercial Scale. US Antimony
completed the Thompson Falls expansion and commissioned the Radersburg flotation
facility, creating a more vertically integrated domestic antimony processing platform.
Additional ore from Stibnite Hill is already being mined and shipped to Radersburg, while
processing capabilities continue to improve through newly installed laboratory and flotation
infrastructure. Thompson Falls furnaces should all become fully operational in the third
quarter, supporting increased throughput and operational efficiency. We believe the
current assets mark an important inflection point, as the transition from construction and
commissioning to full-scale operations should drive higher output, improved utilization rates,
and stronger operating leverage over the coming quarters.
Symbol:
Price:
Market Value (M):
Dividend/Yield:
Fiscal Year End:
Outperform
UAMY (NYSE
American)
$6.58 (52-Wk.: $3-$20)
$1,022
$0.00/0.00%
December
2025A
Estimates
EBITDA (M) FY $(1.4)
EPS FY
$(0.04)
Valuation
EV/EBITDA
NM
FY P/E
NM
2026E
2027E
$(4.2)
$(0.07)
$14.0
$0.06
Trading Data (FactSet)
Shares Outstanding (M):
Float (M):
Avg. Daily Volume (90-day):
NM
NM
Financial Data (FactSet)
Book Value Per Share (MRQ):
Return on Equity (TTM):
Enterprise Value (M):
72.6x
NM
148.2
133.0
9,321,058
$0.92
(19.7)%
$1,015
Two-Year Price Performance Chart
$20
$15
$10
$5
$0
Jan-25
Jan-26
Sources: FactSet, William Blair & Company estimates
DLA Deliveries Set to Accelerate. One of the more immediate catalysts is the continued rampup in DLA shipments. US Antimony delivered its first two shipments totaling approximately
82,000 pounds of antimony ingots, with additional shipments in transit or awaiting inspection
representing more than $9 million of expected revenue. The company also highlighted a
current DLA backlog of approximately $57.3 million and expects at least $9 million-$10 million
of additional government sales during the third quarter.
US Antimony Corporation extracts, processes, and sells antimony, zeolite, silver, and gold mineral products, with
operations in the U.S., Canada, and Mexico.
Please refer to important disclosures on pages 6 – 7. Analyst certification is on page 6.
William Blair or an affiliate does and seeks to do business with companies covered in its research reports. As a
result, investors should be aware that the firm may have a conflict of interest that could affect the objectivity of
this report. This report is not intended to provide personal investment advice. The opinions and recommendations
herein do not take into account individual client circumstances, objectives, or needs and are not intended as
recommendations of particular securities, financial instruments, or strategies to particular clients. The recipient of
this report must make its own independent decisions regarding any securities or financial instruments mentioned
herein.
This report is intended for [email protected]. Unauthorized distribution prohibited.
While US Antimony announced the first two shipments as part of the U.S. Defense Logistics
Agency (DLA) contract of up to $245 million, the company’s second-quarter results fell short
of William Blair/consensus estimates, largely due to lower antimony prices and the DLA
not formally accepting shipments until July. Despite recent and upcoming DLA shipments
this quarter, US Antimony still reduced 2026 guidance due to the potential for lower than
previously expected prices and the continued shift right in DLA shipments. While the company
has potential catalysts ahead, such as further government funding, we will be focused on
upcoming operations, including feedstock and execution. We suggest an equally weighted fair
value of $9 per share, or 37% upside.
Bert Donnes +1 312 364 8563
[email protected]
William Blair
We believe the somewhat guaranteed upcoming production supports a favorable near-term outlook, as increasing DLA deliveries
should begin converting into reported revenue, improved cash flow, and stronger financial results through the remainder of 2026.
2Q26 Earnings
Earnings Metrics
UAMY
1Q26
2Q26
2Q26
2Q26
Actual
Actual
WB
Street
US Antimony
Delta
2Q26 vs WB
2Q26 vs Street
NA
Antimony ('000 lbs)
279
428
1100
NA
-672
Sales Price ($/lb)
$19.92
$13.70
$15.82
NA
($2.12)
NA
CFFO (pre-WC)($MM)
($2)
($4)
($4)
($4)
($0)
$0
Capex ($MM)
$13
$10
FCF ($MM)
($14)
($14)
Source: William Blair Equity Research, Factset, Company Documents
2026 Guidance
New
Old
Revenue ($MM)
$68
$125
Source: William Blair Equity Research, Factset, Company Documents
$1
$1
$10
$9
($4)
($4)
($10)
($10)
UAMY
New vs Old
-46%
US Antimony
WB
$108
Street
$115
Valuation. UAMY shares trade at a 10.6x EV/EBITDAX multiple using our 2030 estimate of $82.9 million compared to the group
average of 9.0x. Based on peer valuations, we believe US Antimony could likely trade at 15.0x; applying a 15.0x multiple suggests a fair
value of $9 per share or 37% upside.
Investment risks include 1) commodity price changes; 2) trade restrictions or tariffs affecting global supply chain and prices; and 3)
the ability to replace inventory at reasonable prices, which could materially impact our estimates.
2 | Neal Dingmann +1 312 801 7835
William Blair
United States Antimony Corporation
Income Statement
Dec-25
Mar-26
Jun-26
Sep-26
Dec-26
Dec-26
Dec-27
Dec-28
Dec-29
Dec-30
($ in millions)
Sales
Sales Other
Sales Other
Other Revenue
Total Revenue
Cost of Product
Cost of Product Other
Cost of Product Other
Cash G&A
Non-cash G&A
Net Marketing Expense
Other Expense
Total Operating Expenses
Adjusted EBITDAX
Interest Expense
Other Expense
Income (loss) before income taxes
Total Taxes
% Total Tax Rate
% Effective Tax (Cash Taxes)
Unadjusted Net Income Before NCI
NCI
Unadjusted Net Income After NCI
Adjustments
Adjusted Net Income
Diluted Sharecount
EPS Diluted
2025
39
0
0
0
$39
29
0
0
10
7
0
1
$48
($1)
0
(4)
($4)
0
0%
0%
($4)
0
($4)
0
($4)
124
($0.04)
1Q26
2Q26
3Q26
15
0
0
0
$15
12
0
0
3
1
0
0
$16
$0
0
(0)
($0)
(0)
28%
0%
($0)
0
($0)
0
($0)
152
($0.00)
4Q26
38
0
0
0
$38
32
0
0
3
1
0
0
$36
$2
0
(0)
$2
1
28%
0%
$1
0
$1
0
$1
152
$0.01
2026
68
0
0
0
$68
57
0
0
14
9
0
1
$81
($4)
0
(4)
($9)
1
-6%
0%
($10)
0
($10)
0
($10)
149
($0.07)
2027
258
0
0
0
$258
231
0
0
13
2
0
0
$246
$14
0
(1)
$13
4
28%
21%
$9
0
$9
0
$9
152
$0.06
2028
335
0
0
0
$335
255
0
0
14
2
0
0
$271
$67
0
(2)
$66
18
28%
28%
$48
0
$48
0
$48
153
$0.31
2029
334
0
0
0
$334
254
0
0
14
2
0
0
$271
$66
0
(2)
$66
18
28%
28%
$47
0
$47
0
$47
153
$0.31
2030
407
0
0
0
$407
310
0
0
15
2
0
0
$327
$83
0
(2)
$82
23
28%
28%
$59
0
$59
0
$59
153
$0.39
FCF Calculation ($ in millions)
CFFO Before WC
Capex
FCF
2025
1Q26
3Q26
4Q26
2026
2027
12
21
(8)
2028
50
2
48
2029
50
102
(52)
2030
62
2
60
Source: Company Reports and William Blair Equity Research
3 | Neal Dingmann +1 312 801 7835
2
28
(25)
7
0
0
0
$7
6
0
0
4
5
0
0
$14
($3)
0
4
($11)
0
0%
0%
($11)
0
($11)
0
($11)
142
($0.08)
(2)
13
(14)
8
0
0
0
$8
7
0
0
4
3
0
1
$15
($4)
0
(7)
$0
0
0%
0%
$0
0
$0
0
$0
152
$0.00
2Q26
(4)
10
(14)
1
11
(10)
3
11
(8)
(2)
45
(47)
William Blair
United States Antimony Corporation
Balance Sheet
($ in millions)
Cash
Accounts Receivable
Inventory
Prepaid Assets
Other
Current Assets
PP&E - Upstream
PP&E - Other
DD&A
Goodwill
Derivatives
Other
Long-term Assets
Total Assets
Accounts Payable
Current Debt
Current Derivatives
Current Taxes Payable
Other Current Liabilities
Current Liabilities
Long-term Debt
Long-term Derivatives
Long-term Taxes Payable
Asset Retirement Obligations
Other
Long-term Liabilities
Total Liabilities
Common Stock
Preferred Stock
Retained Earnings
Non-controlling Interest
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Total Equity
Total Liabilities and Equity
Source: Company Reports and William Blair Equity Research
4 | Neal Dingmann +1 312 801 7835
Dec-25
Mar-26
Jun-26
Sep-26
Dec-26
Dec-26
Dec-27
Dec-28
Dec-29
Dec-30
2025
51
7
13
0
0
$71
42
0
0
0
0
41
$83
$154
7
0
0
0
3
$10
0
0
0
3
0
$3
$13
1
0
0
0
186
(45)
$141
$154
1Q26
26
3
22
1
13
$64
47
0
0
0
0
37
$84
$148
10
0
0
0
4
$13
0
0
0
3
0
$3
$16
(5)
0
0
0
194
(57)
$132
$148
2Q26
63
7
22
2
0
$94
53
0
0
0
0
44
$97
$191
4
0
0
0
3
$6
0
0
0
3
0
$3
$10
(8)
0
0
0
246
(57)
$181
$191
3Q26
53
7
22
2
0
$83
64
0
0
0
0
44
$108
$191
4
0
0
0
3
$6
0
0
(0)
3
0
$3
$10
(8)
0
(0)
0
246
(57)
$182
$191
4Q26
46
7
22
2
0
$77
75
0
0
0
0
44
$119
$196
4
0
0
0
3
$6
2
0
1
3
0
$6
$12
(8)
0
1
0
247
(57)
$184
$196
2026
46
7
22
2
0
$77
75
0
0
0
0
44
$119
$196
4
0
0
0
3
$6
2
0
1
3
0
$6
$12
(8)
0
1
0
247
(57)
$184
$196
2027
73
7
22
2
0
$104
96
0
0
0
0
44
$140
$243
4
0
0
0
3
$6
0
0
1
3
0
$5
$11
(8)
0
48
0
249
(57)
$233
$243
2028
121
7
22
2
0
$152
98
0
0
0
0
44
$142
$293
4
0
0
0
3
$6
0
0
1
3
0
$5
$11
(8)
0
95
0
252
(57)
$282
$293
2029
69
7
22
2
0
$99
200
0
0
0
0
44
$244
$343
4
0
0
0
3
$6
0
0
1
3
0
$5
$11
(8)
0
143
0
254
(57)
$332
$343
2030
128
7
22
2
0
$159
202
0
0
0
0
44
$246
$405
4
0
0
0
3
$6
0
0
1
3
0
$5
$11
(8)
0
202
0
256
(57)
$394
$405
William Blair
United States Antimony Corporation
Statement of Cash Flows
($ in millions)
Net Income
DD&A
Non-cash G&A
Non-cash Taxes
Other
CFFO Before WC
Change in Current Assets
Change in Current Liabilities
Other
CFFO
Capex
Capex Other
Divestitures
Acquisitions
Other
CFFI
Regular Dividends
Shares Issued
Shares Repurchased
Debt Issued
Debt Repurchased
Other
CFFF
Currency impact
Total Change In Cash
Dec-25
Mar-26
Jun-26
Sep-26
Dec-26
Dec-26
Dec-27
Dec-28
Dec-29
Dec-30
2025
1Q26
(11)
0
5
0
4
($2)
(8)
(2)
(2)
($12)
(13)
0
0
0
0
($13)
0
2
(5)
0
(0)
3
($0)
0
($25)
2Q26
3Q26
4Q26
2026
(10)
1
9
1
(3)
($2)
(10)
(5)
(2)
($18)
(26)
0
0
0
12
($33)
0
51
(8)
2
(0)
1
$46
0
($5)
2027
2028
48
0
2
0
0
$50
0
0
50
$50
(2)
0
0
0
0
($2)
0
0
0
0
0
(0)
($0)
0
$48
2029
47
0
2
0
0
$50
0
0
50
$50
(2)
(100)
0
0
0
($102)
0
0
0
0
0
(0)
($0)
0
($52)
2030
59
0
2
0
0
$62
0
0
62
$62
(2)
0
0
0
0
($2)
0
0
0
0
0
(0)
($0)
0
$60
Source: Company Reports and William Blair Equity Research
5 | Neal Dingmann +1 312 801 7835
(4)
1
7
0
(2)
$2
(17)
5
2
($10)
(28)
0
0
0
(60)
($87)
0
110
(0)
0
(0)
20
$130
0
$33
0
1
3
0
(7)
($4)
(2)
(3)
(4)
($9)
(10)
0
0
0
12
$1
0
49
(3)
0
(0)
(2)
$44
0
$37
(0)
0
1
(0)
0
$1
0
0
1
$1
(2)
0
0
0
0
($11)
0
0
0
0
0
(0)
($0)
0
($10)
1
0
1
1
0
$3
0
0
3
$3
(2)
0
0
0
0
($11)
0
0
0
2
0
(0)
$2
0
($6)
9
0
2
1
0
$12
0
0
12
$12
(2)
0
0
0
38
$17
0
0
0
6
(8)
(0)
($2)
0
$27
William Blair
IMPORTANT DISCLOSURES
William Blair or an affiliate is a market maker in the security of United States Antimony Corporation.
William Blair or an affiliate expects to receive or intends to seek compensation for investment banking services from United States Antimony
Corporation or an affiliate within the next three months.
Officers and employees of William Blair or its affiliates (other than research analysts) may have a financial interest in the securities of United
States Antimony Corporation.
This report is available in electronic form to registered users via R*Docs™ at https://williamblairlibrary.bluematrix.com or
www.williamblair.com.
Please contact us at +1 312 236 1600 or consult https://www.williamblair.com/equity-research/coverage for all disclosures.
Neal Dingmann attests that 1) all of the views expressed in this research report accurately reflect his/her personal views about any and
all of the securities and companies covered by this report, and 2) no part of his/her compensation was, is, or will be related, directly or
indirectly, to the specific recommendations or views expressed by him/her in this report. We seek to update our research as appropriate.
Other than certain periodical industry reports, the majority of reports are published at irregular intervals as deemed appropriate by the
research analyst.
DOW JONES: 53791.90
S&P 500: 7728.20
NASDAQ: 26445.40
United States Antimony Corporation Rating History as of 08/11/2026
powered by: BlueMatrix
I:OP
10/20/25
20
15
10
5
0
Oct 23
Jan 24
Apr 24
Jul 24
Oct 24
Jan 25
Apr 25
Jul 25
Oct 25
Jan 26
Apr 26
Jul 26
Closing Price
OP:Outperform Mkt:Market Perform UP:Under Perform NR:Not Rated I:Initiation of Coverage D:Dropped Coverage
Source: FactSet & William Blair
Current Rating for UAMY: Outperform
Additional information is available upon request.
Current Rating Distribution (as of August 12, 2026):
Coverage Universe
Percent
Inv. Banking Relationships *
Outperform (Buy)
Market Perform (Hold)
Underperform (Sell)
72
28
1
Outperform (Buy)
Market Perform (Hold)
Underperform (Sell)
Percent
14
3
0
*Percentage of companies in each rating category that are investment banking clients, defined as companies for which William Blair has
received compensation for investment banking services within the past 12 months.
The compensation of the research analyst is based on a variety of factors, including performance of his or her stock recommendations;
contributions to all of the firm’s departments, including asset management, corporate finance, institutional sales, and retail brokerage; firm
profitability; and competitive factors.
6 | Neal Dingmann +1 312 801 7835
William Blair
OTHER IMPORTANT DISCLOSURES
Stock ratings and valuation methodologies: William Blair & Company, L.L.C. uses a three-point system to rate stocks. Individual ratings reflect
the expected performance of the stock relative to the broader market (generally the S&P 500, unless otherwise indicated) over the next
12 months. The assessment of expected performance is a function of near-, intermediate-, and long-term company fundamentals, industry
outlook, confidence in earnings estimates, valuation (and our valuation methodology), and other factors. Outperform (O) - stock expected
to outperform the broader market over the next 12 months; Market Perform (M) - stock expected to perform approximately in line with
the broader market over the next 12 months; Underperform (U) - stock expected to underperform the broader market over the next 12
months; not rated (NR) - the stock is not currently rated. The valuation methodologies include (but are not limited to) price-to-earnings
multiple (P/E), relative P/E (compared with the relevant market), P/E-to-growth-rate (PEG) ratio, market capitalization/revenue multiple,
enterprise value/EBITDA ratio, discounted cash flow, and others. Stock ratings and valuation methodologies should not be used or relied
upon as investment advice. Past performance is not necessarily a guide to future performance.
The ratings and valuation methodologies reflect the opinion of the individual analyst and are subject to change at any time.
Our salespeople, traders, and other professionals may provide oral or written market commentary, short-term trade ideas, or trading
strategies-to our clients, prospective clients, and our trading desks-that are contrary to opinions expressed in this research report. Certain
outstanding research reports may contain discussions or investment opinions relating to securities, financial instruments and/or issuers
that are no longer current. Investing in securities involves risks. This report does not contain all the material information necessary for an
investment decision. Always refer to the most recent report on a company or issuer. Our asset management and trading desks may make
investment decisions that are inconsistent with recommendations or views expressed in this report. We will from time to time have long
or short positions in, act as principal in, and buy or sell the securities referred to in this report. Our research is disseminated primarily
electronically, and in some instances in printed form. Research is simultaneously available to all clients. This research report is for our clients
only. No part of this material may be copied or duplicated in any form by any means or redistributed without the prior written consent of
William Blair & Company, L.L.C.
This is not in any sense an offer or solicitation for the purchase or sale of a security or financial instrument.
The factual statements herein have been taken from sources we believe to be reliable, but such statements are made without any
representation as to accuracy or completeness or otherwise, except with respect to any disclosures relative to William Blair or its research
analysts. Opinions expressed are our own unless otherwise stated and are subject to change without notice. Prices shown are approximate.
This report or any portion hereof may not be copied, reprinted, sold, or redistributed or disclosed by the recipient to any third party, by
content scraping or extraction, automated processing, or any other form or means, without the prior written consent of William Blair. Any
unauthorized use is prohibited.
If the recipient received this research report pursuant to terms of service for, or a contract with William Blair for, the provision of research
services for a separate fee, and in connection with the delivery of such research services we may be deemed to be acting as an investment
adviser, then such investment adviser status relates, if at all, only to the recipient with whom we have contracted directly and does not
extend beyond the delivery of this report (unless otherwise agreed specifically in writing). If such recipient uses these research services in
connection with the sale or purchase of a security referred to herein, William Blair may act as principal for our own account or as riskless
principal or agent for another party. William Blair is and continues to act solely as a broker-dealer in connection with the execution of any
transactions, including transactions in any securities referred to herein.
For important disclosures, please visit our website at williamblair.com.
This material is distributed in the United Kingdom and the European Economic Area (EEA) by William Blair International, Ltd., authorised
and regulated by the Financial Conduct Authority (FCA). William Blair International, Limited is a limited liability company registered in
England and Wales with company number 03619027. This material is only directed and issued to persons regarded as Professional investors
or equivalent in their home jurisdiction, or persons falling within articles 19 (5), 38, 47, and 49 of the Financial Services and Markets Act of
2000 (Financial Promotion) Order 2005 (all such persons being referred to as "relevant persons"). This document must not be acted on or
relied on by persons who are not "relevant persons."
This report is being furnished in Brazil on a confidential basis and is addressed to the addressee personally, and for its sole benefit. This
does not constitute an offer or solicitation for the purchase or sale of a security by any means that would constitute a public offering in Brazil
under the regulations of the Brazilian Securities and Exchange Commission (Comissão de Valores Mobiliários) or an unauthorized distribution
under Brazilian laws and regulations. The securities are authorized for trading on non-Brazilian securities markets, and this report and all
the information herein is intended solely for professional investors (as defined by the applicable Brazilian regulation) who may only acquire
these securities through a non-Brazilian account, with settlement outside Brazil in a non-Brazilian currency.
“William Blair” and “R*Docs” are registered trademarks of William Blair & Company, L.L.C. Copyright 2026, William Blair & Company, L.L.C.
All rights reserved.
William Blair & Company, L.L.C. licenses and applies the SASB Materiality Map® and SICSTM in our work.
7 | Neal Dingmann +1 312 801 7835
Equity Research Directory
John Kreger, Partner Director of Research +1 312 364 8612
Kyle Harris, CFA, Partner Operations Manager
CONSUMER
Healthcare Technology and Services
Sharon Zackfia, CFA, Partner +1 312 364 5386
Group Head–Consumer
Lifestyle and Leisure Brands, Restaurants, Automotive/E-commerce
Ryan S. Daniels, CFA, Partner +1 312 364 8418
Group Head–Healthcare Technology and Services
Healthcare Technology, Healthcare Services
Phillip Blee, CPA +1 312 801 7874
Home and Outdoor, Automotive Parts and Services, Discount and
Convenience
Steven Lichtman +1 646 561 9373
Medical Technology
Jon Andersen, CFA, Partner
Consumer Products
+1 312 364 8697
Dylan Carden +1 312 801 7857
E-commerce, Specialty Retail
ECONOMICS
Richard de Chazal, CFA
+44 20 7868 4489
ENERGY AND POWER TECHNOLOGIES
Jed Dorsheimer +1 617 235 7555
Group Head–Energy and Power Technologies
Generation, Efficiency, Storage
Neal Dingmann +1 312 801 7835
Oil and Gas, Rare Earth
Tim Mulrooney, Partner +1 312 364 8123
Energy and Environmental Services
Mark Shooter +1 617 235 7593
Generation, Storage
FINANCIAL SERVICES AND TECHNOLOGY
Adam Klauber, CFA, Partner +1 312 364 8232
Group Head–Financial Services and Technology
Financial Analytic Service Providers, Insurance Brokers, Property &
Casualty Insurance
Andrew W. Jeffrey, CFA
Fintech
+1 415 796 6896
Cristopher Kennedy, CFA
Fintech, Specialty Finance
+1 312 364 8596
Jeff Schmitt +1 312 364 8106
Wealthtech, Wealth Management, Capital Markets Technology
GLOBAL SERVICES
Tim Mulrooney, Partner +1 312 364 8123
Group Head–Global Services
Commercial and Residential Services
Andrew Nicholas, CPA +1 312 364 8689
Consulting, HR Technology, Information Services
Trevor Romeo, CFA +1 312 801 7854
Staffing, Waste and Recycling
HEALTHCARE
Matt Phipps, Ph.D., Partner
Group Head–Biotechnology
+1 312 364 8602
Andy T. Hsieh, Ph.D., Partner
+1 312 364 5051
Sami Corwin, Ph.D.
Jared Haase, CFA +1 312 364 5135
Healthcare Delivery, Pharmaceutical Outsourcing and Services
Brandon Vazquez, CFA +1 212 237 2776
Dental, Animal Health, Medical Technology
Life Sciences
Matt Larew, Partner +1 312 801 7795
Life Science Tools, Bioprocessing, Healthcare Delivery
INDUSTRIALS
Brian Drab, CFA, Partner +1 312 364 8280
Co-Group Head–Industrials
Advanced Manufacturing, Industrial Technology
Ryan Merkel, CFA , Partner +1 312 364 8603
Co-Group Head–Industrials
Building Products, Specialty Distribution
Louie DiPalma, CFA, Partner +1 312 364 5437
Aerospace and Defense, Smart Infrastructure
Ross Sparenblek, CFA +1 312 364 8361
Diversified Industrials, Robotics, and Automation
TECHNOLOGY, MEDIA, AND COMMUNICATIONS
Jason Ader, CFA, Partner +1 617 235 7519
Co-Group Head–Technology, Media, and Communications
Infrastructure Software
Arjun Bhatia, Partner +1 312 364 5696
Co-Group Head–Technology, Media, and Communications
Software
Dylan Becker, CFA
Software
+1 312 364 8938
Louie DiPalma, CFA, Partner
Government Technology
+1 312 364 5437
Jonathan Ho, Partner +1 312 364 8276
Cybersecurity, Security Technology
Patrick McIlwee, CFA
Software
+1 312 364 8655
Sebastien Naji +1 212 245 6508
Infrastructure Software, Semiconductor and Infrastructure Systems
Maggie Nolan, CPA, Partner
IT Services
+1 312 364 5090
Ralph Schackart III, CFA, Partner
Internet and Digital Media
Biotechnology
+1 312 801 7783
Lachlan Hanbury-Brown
+1 312 364 8125
Myles R. Minter, Ph.D., Partner
+1 617 235 7534
+1 312 364 8230
+1 312 364 8753
Stephen Sheldon, CFA, CPA, Partner +1 312 364 5167
Vertical Technology – Real Estate, Education, Restaurant/Hospitality
EDITORIAL AND SUPERVISORY ANALYSTS
Steve Goldsmith, Head Editor and SA +1 312 364 8540
Katie Anderson, Editor and SA +44 20 7868 4451
Audrey Majors, Editor and SA +1 312 364 8992
Beth Pekol Porto, Editor and SA +1 312 364 8924
Lisa Zurcher, Editor and SA +44 20 7868 4549